Transplant Commercialization

Transplant Commercialization is the illicit practice of commodifying human organs, tissues, or transplant services through financial transactions that violate ethical norms and legal prohibitions within the global framework of cross-border organ transplantation.

84

Publications

3.3K

Citations

212

Authors

106

Institutions

Publications per year

2017–2026

7

Authors

212

  1. JS
    James S. Taylor

    Cleveland Clinic, United States

    3 publications · 63 citations

    3

    h-index

  2. MS
    Mark Schweda

    University of Göttingen, Germany

    3 publications · 75 citations

    3

    h-index

  3. RW
    Roger W. Evans

    Mayo Clinic, United States

    3 publications · 114 citations

    3

    h-index

  4. SS
    Silke Schicktanz

    Universitätsmedizin Göttingen, Germany

    3 publications · 75 citations

    3

    h-index

  5. LT
    Leigh Turner

    University of Minnesota, United States

    2 publications · 58 citations

    2

    h-index

1–5 of 212

Venues

  1. PubMed

    Repository · 7 publications · 189 citations

    7

    h-index

  2. Transplantation

    4 publications · 162 citations

    4

    h-index

  3. Cambridge Quarterly of Healthcare Ethics

    4 publications · 98 citations

    4

    h-index

  4. Transplantation Proceedings

    4 publications · 94 citations

    4

    h-index

  5. American Journal of Transplantation

    4 publications · 138 citations

    4

    h-index

1–5